Targeting TFAM K76 acetylation attenuates mitochondrial dysfunction and kidney injury in diabetic kidney disease.
Saved in:
| Title: | Targeting TFAM K76 acetylation attenuates mitochondrial dysfunction and kidney injury in diabetic kidney disease. |
|---|---|
| Authors: | Fu T; Shandong Provincial Key Medical and Health Laboratory of Cell Metabolism, Jinan Central Hospital, Shandong University, Jinan, 250013, Shandong, China.; Shandong Provincial Key Medical and Health Laboratory of Cell Metabolism, Central Hospital Affiliated to Shandong First Medical University, Jinan, 250013, Shandong, China., Sun S; Shandong Provincial Key Medical and Health Laboratory of Cell Metabolism, Central Hospital Affiliated to Shandong First Medical University, Jinan, 250013, Shandong, China., Wang Z; Shandong Provincial Key Medical and Health Laboratory of Cell Metabolism, Jinan Central Hospital, Shandong University, Jinan, 250013, Shandong, China.; Shandong Provincial Key Medical and Health Laboratory of Cell Metabolism, Central Hospital Affiliated to Shandong First Medical University, Jinan, 250013, Shandong, China., Zhao F; Department of Traditional Chinese Medicine, Central Hospital Affiliated to Shandong First Medical University, Jinan, 250013, Shandong, China., Zhen J; Department of Pathology, Cheeloo College of Medicine, Qilu Hospital of Shandong University, Jinan, 250012, Shandong, China., Ji X; Department of Pulmonary and Critical Care Medicine, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, 250021, Shandong, China.; Medical Science and Technology Innovation Center, Shandong First Medical University & Shandong Academy of Medical Sciences, Shandong, 250117, Jinan, China., Xue F; Shandong Provincial Key Medical and Health Laboratory of Cell Metabolism, Central Hospital Affiliated to Shandong First Medical University, Jinan, 250013, Shandong, China., Mu Q; Department of Pulmonary and Critical Care Medicine, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, 250021, Shandong, China.; Medical Science and Technology Innovation Center, Shandong First Medical University & Shandong Academy of Medical Sciences, Shandong, 250117, Jinan, China., Wang Y; Department of Pulmonary and Critical Care Medicine, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, 250021, Shandong, China.; Medical Science and Technology Innovation Center, Shandong First Medical University & Shandong Academy of Medical Sciences, Shandong, 250117, Jinan, China., Liu Y; Department of Pulmonary and Critical Care Medicine, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, 250021, Shandong, China. liuyishanyi@email.sdu.edu.cn.; Medical Science and Technology Innovation Center, Shandong First Medical University & Shandong Academy of Medical Sciences, Shandong, 250117, Jinan, China. liuyishanyi@email.sdu.edu.cn., Wan Q; Shandong Provincial Key Medical and Health Laboratory of Cell Metabolism, Jinan Central Hospital, Shandong University, Jinan, 250013, Shandong, China. wanqiang@sdu.edu.cn.; Shandong Provincial Key Medical and Health Laboratory of Cell Metabolism, Central Hospital Affiliated to Shandong First Medical University, Jinan, 250013, Shandong, China. wanqiang@sdu.edu.cn. |
| Source: | Cardiovascular diabetology [Cardiovasc Diabetol] 2026 Feb 03; Vol. 25 (1). Date of Electronic Publication: 2026 Feb 03. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 101147637 Publication Model: Electronic Cited Medium: Internet ISSN: 1475-2840 (Electronic) Linking ISSN: 14752840 NLM ISO Abbreviation: Cardiovasc Diabetol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
